dihexa safety concerns hgf c-met cancer risk Developing pathway inhibitors for therapy: progress and challenges: Trends in Molecular Medicine Dihexa (PNB-0408) | c-Met/HGFR Activator
Dihexa (PNB 0408) c Met HGFR Activator MedChemExpress Frontiers The Function of the HGF c Met Axis in Hepatocellular Carcinoma Targeting cancer associated fibroblast activated HGF c MET pathway inhibits extrahepatic cholangiocarcinoma progression and restores gemcitabine therapeutic sensitivity ScienceDirect Small molecule activation of the neurotrophin hepatocyte growth factor to treat Alzheimer disease
Pay in 4 interest-free payments of $5.67 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Jul 31 - Aug 5



